New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

New multi-center US study finds RSV co-infection in children under two is not linked to worse clinical outcomes, challenging ...

Recent data shows that most infants are receiving RSV vaccination in the US, but rates vary by race and birth month.

In a worst-case scenario, infants can go on to develop bronchiolitis and pneumonia, with babies aged 0 to 2 months being ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

Headlines as of late have sounded alarms about the spread of the avian flu, known more colloquially as the bird flu. Over the last year, a highly pathogenic avian influenza, A(H5N1), has sporadically ...

The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long immunity ... This means the lower airway is getting tight.

Beyfortus contains the monoclonal antibody, nirsevimab, in a prefilled injection used to prevent RSV lower respiratory tract disease (LRTD) in newborns and infants born during or entering their ...

This is the final week of the Get Your Body Right series. And we have a special two week plan you can do on repeat. This is why you should keep going. For the final week of the Get Your Body Right ...